Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

Retina

Volumn 31, Issue 6, 2011, Pages 1009-1027

  Googe, Joseph ^a   Brucker, Alexander J ^b   Bressler, Neil M ^c   Qin, Haijing ^d   Aiello, Lloyd P ^e   Antoszyk, Andrew ^f   Beck, Roy W ^d   Bressler, Susan B ^c   Ferris, Frederick L ^g   Glassman, Adam R ^d   Marcus, Dennis ^h   Stockdale, Cynthia R ^d  

^a Southeastern Retina Associates   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JAEB CENTER FOR HEALTH RESEARCH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Charlotte Eye Ear Nose and Throat Associates   (United States)

^g NATIONAL EYE INSTITUTE   (United States)

^h Southeast Retina Center   (United States)

Author keywords

diabetic macular edema; Diabetic Retinopathy Clinical Research Network; panretinal photocoagulation; Proliferative diabetic retinopathy; randomized clinical trial; ranibizumab; triamcinolone

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; POSTOPERATIVE CARE; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 79958268827     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318217d739     Document Type: Article

References (27)

1. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-396.
2. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1291.
3. Myers SM. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol 1980; 90:210-216.
4. McDonald HR, Schatz H. Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1985;92:388-393. (Pubitemid 15099102)
5. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98: 766-785.
6. Shimura M, Yasuda K, Nakazawa T, et al. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003;110:2386-2394. (Pubitemid 37485170)
7. Diabetic Retinopathy Clinical Research Network. Observa-tional study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in1or4 sittings. Arch Ophthalmol 2009;127:132-140.
8. Antonetti DA, Barber AJ, Hollinger LA, et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Bio Chem 1999;274:23463-23467.
9. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-1487. (Pubitemid 24356306)
10. Zacks DN, Johnson MW. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy. Retina 2005;25:135-140. (Pubitemid 40365935)
11. Maia OO Jr, Takahashi BS, Costa RA, et al. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a random-ized clinical trial. Am J Ophthalmol 2009;147:291-297 e2.
12. Cunningham ET Jr, Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112:1747-1757.
13. Gillies MC, Sutter FK, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, random-ized clinical trial. Ophthalmology 2006;113:1533-1538. (Pubitemid 44292310)
14. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927. (Pubitemid 34465226)
15. Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards A, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Oph-thalmal 2007;114:1860-1867.
16. Nguyen QD, Shah SM, Heier JS, et al. Primary end point (six months) results of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology 2009;116:2175-2181 e1.
17. The Diabetic Retinopathy Clinical Research Network. Ran-domized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077 e35.
18. Bressler NM, Edwards AR, Beck RW, et al. Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal tri-amcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol 2009;127:1566-1571.
19. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 2003;135:194-205. (Pubitemid 36151797)
20. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007; 125: 469-480. (Pubitemid 46596718)
21. Diabetic Retinopathy Clinical Research Network. A random-ized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1449, 9 e1-10 e1.
22. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs\an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98: 786-806.
23. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: Wiley; 1987:255-259.
24. Zou G A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706. (Pubitemid 38405384)
25. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelettherapy-I: prevention ofdeath, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308: 81-106.
26. Diabetic Retinopathy Clinical Research Network. The course ofresponse to focal/grid photocoagulation for diabetic macular edema. Retina 2009;29:1436-1443.
27. Ockrim ZK, Sivaprasad S, Falk S, et al. Intravitreal tri-amcinolone versus laser photocoagulation for persistent diabetic macular oedema. Br J Ophthalmol 2008;92:795-799. (Pubitemid 351839571)